Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models

AIM: To assess the performance of BALAD, BALAD-2 and their component biomarkers in predicting outcome of hepatocellular carcinoma (HCC) patients after liver transplant. METHODS: BALAD score and BALAD-2 class are derived from bilirubin, albumin, alpha-fetoprotein (AFP), Lens culinaris agglutinin-reac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wongjarupong, Nicha, Negron-Ocasio, Gabriela M, Chaiteerakij, Roongruedee, Addissie, Benyam D, Mohamed, Essa A, Mara, Kristin C, Harmsen, William S, Theobald, J Paul, Peters, Brian E, Balsanek, Joseph G, Ward, Melissa M, Giama, Nasra H, Venkatesh, Sudhakar K, Harnois, Denise M, Charlton, Michael R, Yamada, Hiroyuki, Algeciras-Schimnich, Alicia, Snyder, Melissa R, Therneau, Terry M, Roberts, Lewis R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871827/
https://www.ncbi.nlm.nih.gov/pubmed/29599607
http://dx.doi.org/10.3748/wjg.v24.i12.1321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871827/
https://www.ncbi.nlm.nih.gov/pubmed/29599607
http://dx.doi.org/10.3748/wjg.v24.i12.1321

Ejemplares similares